Edgestream Partners L.P. Has $865,000 Position in Cardinal Health, Inc. (NYSE:CAH)

Edgestream Partners L.P. boosted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 225.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,313 shares of the company’s stock after acquiring an additional 5,066 shares during the quarter. Edgestream Partners L.P.’s holdings in Cardinal Health were worth $865,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Frazier Financial Advisors LLC raised its holdings in shares of Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock valued at $28,000 after purchasing an additional 104 shares in the last quarter. Promus Capital LLC acquired a new position in Cardinal Health during the fourth quarter worth $30,000. AM Squared Ltd bought a new position in Cardinal Health during the third quarter valued at about $33,000. Kentucky Trust Co acquired a new stake in shares of Cardinal Health in the fourth quarter worth about $41,000. Finally, HHM Wealth Advisors LLC lifted its position in shares of Cardinal Health by 57.6% in the fourth quarter. HHM Wealth Advisors LLC now owns 394 shares of the company’s stock worth $47,000 after buying an additional 144 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on CAH. Morgan Stanley raised their price objective on Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a research note on Friday, January 31st. Argus set a $148.00 price target on shares of Cardinal Health in a research report on Tuesday, February 4th. Jefferies Financial Group upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $140.00 to $150.00 in a research note on Wednesday, February 5th. Wells Fargo & Company raised their target price on shares of Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. Finally, Mizuho began coverage on shares of Cardinal Health in a research report on Wednesday, December 4th. They set an “outperform” rating and a $139.00 target price for the company. Four research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $139.36.

Cardinal Health Stock Up 0.3 %

CAH stock opened at $124.25 on Wednesday. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $132.84. The company has a market cap of $30.01 billion, a PE ratio of 23.18, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. The business’s 50-day simple moving average is $125.82 and its 200 day simple moving average is $119.08.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.63%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 37.69%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.